Immutep

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). 

CEO
Marc Voigt
CEOMarc Voigt
Employees
—
Employees—
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1987
Founded1987
Employees
—
Employees—

IMMP Key Statistics

Market cap
240.23M
Market cap240.23M
Price-Earnings ratio
-7.52
Price-Earnings ratio-7.52
Dividend yield
—
Dividend yield—
Average volume
107.65K
Average volume107.65K
High today
$1.67
High today$1.67
Low today
$1.60
Low today$1.60
Open price
$1.64
Open price$1.64
Volume
90.36K
Volume90.36K
52 Week high
$2.72
52 Week high$2.72
52 Week low
$1.32
52 Week low$1.32

IMMP News

Yahoo Finance 6d
With 51% institutional ownership, Immutep Limited is a favorite amongst the big guns - Yahoo Finance

...

With 51% institutional ownership, Immutep Limited is a favorite amongst the big guns - Yahoo Finance

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.